By exploring ERCC3 gene genomic alterations in breast cancers using c-BioPortal, we found that ERCC3 amplification concentratedly occurred in breast invasive cancer NOS, and most of deep deletions occurred in metaplastic breast cancer. Here, ERCC3 is linked to invasive breast carcinoma.